China Pharma Holdings Inc
Research China Pharma Holdings Inc (CPHI) on Bullrun: market cap USD 25.41M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCPHI
- ExchangeNYSE MKT
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 25.41M
- Financial periodFY2025
- RevenueUSD 4.14M
- Revenue growth-8.5%
- Net income-USD 3.19M
- Free cash flowUSD 88.94K
- Gross margin-3.2%
Valuation Snapshot
latest market cap is USD 25.41M.
About China Pharma Holdings Inc
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain;
Frequently asked questions
What is China Pharma Holdings Inc's market cap?
China Pharma Holdings Inc's market capitalization is USD 25.41M.
What does China Pharma Holdings Inc do?
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.